Abstract
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) acted as a tumor suppressor in endometrial carcinoma (EC). However, the correlation between EFEMP1 and estrogen is unknown. Here, we reported that the expression of EFEMP1 was conversely associated with ERα in endometrial carcinoma tissues. In endometrial carcinoma cells, estrogen/ERα signaling significantly suppressed the expression of EFEMP1. Moreover, chromatin immunoprecipitation (CHIP) and dual-luciferase reporter assays demonstrate that estrogen/ERα bound to the estrogen response element (ERE) located in EFEMP1 promoter and repressed its expression. Besides, in vitro and in vivo, EFEMP1 could remarkably suppress the expression of epithelial-mesenchymal transition (EMT) markers such as Vimentin, Snail and the Wnt/β-catenin target genes like Cyclin-D1 and c-Myc, which could be restored when EFEMP1 was silenced. In addition, XAV93920 (the inhibitor of the Wnt/β-catenin pathway) blocked and LiCl (the activator of the Wnt/β-catenin pathway) enhanced the effect of EFEMP1 on EMT. In conclusion, we demonstrated that estrogen/ERα signal suppresses EFEMP1. Besides, EFEMP1 inhibits EMT via interfering the Wnt/β-catenin signaling.
Highlights
Myometrial invasion ≤1/2 >1/2 Lymph node metastasis
Forward: 5’-TGATTGGTCTCGTCTGGCG-3’ Reverse : 5’-CATGCCCTCTACACATTTTCCC-3’ Forward: 5’-TTGCTACTGGAACAGGGACAC-3’ Reverse : 5’-CCCGTGTGTTAGTTCTGCTGT-3’ Forward: 5’-TGCGTGAAATGGAAGAGAACT-3’ Reverse : 5’-TCAGGTTCAGGGAGGAAAAGT-3’ Forward: 5’-TCCAGAGTTTACCTTCCAGCA-3’
Β-catenin Cyclin-D1 c-Myc β-actin Primers for CHIP
Summary
Myometrial invasion ≤1/2 >1/2 Lymph node metastasis
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
